Literature DB >> 8416956

Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor.

D A Lomas1, D L Evans, C Upton, G McFadden, R W Carrell.   

Abstract

The myxoma and malignant rabbit fibroma poxviruses are lethal tumorigenic viruses of rabbits whose virulence is modulated by the production of a virus-encoded secreted serine proteinase inhibitor, SERP-1. This viral protein was detected in medium harvested from myxoma and malignant rabbit fibroma virus-infected cells, and its inhibitory profile has been characterized by gel and kinetic analysis. SERP-1 forms complexes with and inhibits the human fibrinolytic enzymes plasmin, urokinase, and two-chain tissue-type plasminogen activator (association rate constants 3.4 x 10(4), 4.3 x 10(4), and 3.6 x 10(4) M-1 s-1 respectively). It is also able to inhibit C1S, the first enzyme in the complement cascade with an association rate constant which was unaffected by the addition of heparin (1.3 x 10(3) M-1 s-1). SERP-1 acts as a substrate for and is cleaved by thrombin, porcine trypsin, human neutrophil elastase, porcine pancreatic elastase, thermolysin, subtilisin, bovine alpha-chymotrypsin, and factor Xa. Incubation with kallikrein and cathepsin G had no effect. The structure of SERP-1 has been modeled on other members of the serpin family which revealed the characteristic serpin architecture apart from the absence of the D-helix. Structural analysis and kinetic assays demonstrate that the absence of this region does not prevent inhibitory activity and furthermore allow the identification of cysteine residues involved in internal and intermolecular disulfide bonding.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8416956

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  A functional NSP4 enterotoxin peptide secreted from rotavirus-infected cells.

Authors:  M Zhang; C Q Zeng; A P Morris; M K Estes
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Complete sequence and genomic analysis of murine gammaherpesvirus 68.

Authors:  H W Virgin; P Latreille; P Wamsley; K Hallsworth; K E Weck; A J Dal Canto; S H Speck
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  alpha(1)-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1.

Authors:  Thomas Sulikowski; Bryan A Bauer; Philip A Patston
Journal:  Protein Sci       Date:  2002-09       Impact factor: 6.725

4.  Serpins in unicellular Eukarya, Archaea, and Bacteria: sequence analysis and evolution.

Authors:  Thomas H Roberts; Jorn Hejgaard; Neil F W Saunders; Ricardo Cavicchioli; Paul M G Curmi
Journal:  J Mol Evol       Date:  2004-10       Impact factor: 2.395

5.  Activation of caspases in pig kidney cells infected with wild-type and CrmA/SPI-2 mutants of cowpox and rabbitpox viruses.

Authors:  J Macen; A Takahashi; K B Moon; R Nathaniel; P C Turner; R W Moyer
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Post-translational modification of the myxoma-virus anti-inflammatory serpin SERP-1 by a virally encoded sialyltransferase.

Authors:  P Nash; M Barry; B T Seet; K Veugelers; S Hota; J Heger; C Hodgkinson; K Graham; R J Jackson; G McFadden
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

Review 7.  Viral serpin therapeutics from concept to clinic.

Authors:  Hao Chen; Donghang Zheng; Jennifer Davids; Mee Yong Bartee; Erbin Dai; Liying Liu; Lyubomir Petrov; Colin Macaulay; Robert Thoburn; Eric Sobel; Richard Moyer; Grant McFadden; Alexandra Lucas
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

8.  Viral-derived Serp-1 as an adjunctive therapy for percutaneous coronary intervention: another not ready for prime time player?

Authors:  Jane A Leopold
Journal:  Circ Cardiovasc Interv       Date:  2010-12       Impact factor: 6.546

9.  Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.

Authors:  S Sheng; B Truong; D Fredrickson; R Wu; A B Pardee; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

10.  Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1 beta-converting enzyme.

Authors:  F Petit; S Bertagnoli; J Gelfi; F Fassy; C Boucraut-Baralon; A Milon
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.